We hypothesised therefore that melanoma cells can utilise either CDKN1A/P21 or CDKN1C/P57 to mediate cell cycle arrest induced by MITF and this is reflected in the expression levels of the alternate CDK inhibitors in different melanoma cell lines (Fig. S5). The gene discussed is MITF; the disease is melanoma.